(Q67835427)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1779263%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

title

Endometrial carcinoma in tamoxifen-treated breast cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1779263%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

Endometrial Carcinoma in Tamoxifen-Treated Breast Cancer Patients (English)

1 reference

https://api.crossref.org/works/10.1080/1120009X.1991.11739104

21 November 2022

main subject

endometrial carcinoma

1 reference

1 reference

https://api.crossref.org/works/10.1080/1120009X.1991.11739104

21 November 2022

1 reference

https://api.crossref.org/works/10.1080/1120009X.1991.11739104

21 November 2022

1 reference

G. Spinelli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1779263

21 November 2022

N. Bardazzi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1779263

21 November 2022

A. Citernesi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1779263

21 November 2022

M. Fontanarosa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1779263

21 November 2022

P. Curiel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1779263

21 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1779263

21 November 2022

publication date

1 August 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1779263%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

18 September 2019

http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

1 reference

https://api.crossref.org/works/10.1080/1120009X.1991.11739104

21 November 2022

published in

Journal of Chemotherapy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1779263%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1779263%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1779263%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

page(s)

267-270

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1779263%20AND%20SRC:MED&resulttype=core&format=json

The pharmacology and clinical uses of tamoxifen

18 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1080/1120009X.1991.11739104

Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. 'Nolvadex' Adjuvant Trial Organisation

21 November 2022

3

1 reference

https://api.crossref.org/works/10.1080/1120009X.1991.11739104

The prevention of breast cancer

21 November 2022

4

1 reference

https://api.crossref.org/works/10.1080/1120009X.1991.11739104

Tamoxifen and benign breast problems

21 November 2022

5

1 reference

https://api.crossref.org/works/10.1080/1120009X.1991.11739104

Estrogen-Like Action of Tamoxifen on Vaginal Epithelium in Breast Cancer Patients

21 November 2022

6

1 reference

https://api.crossref.org/works/10.1080/1120009X.1991.11739104

Endocrine Consequences of Continuous Antiestrogen Therapy with Tamoxifen in Premenopausal Women

21 November 2022

9

1 reference

https://api.crossref.org/works/10.1080/1120009X.1991.11739104

Endometriosis developing during tamoxifen therapy

21 November 2022

10

1 reference

https://api.crossref.org/works/10.1080/1120009X.1991.11739104

Endometrial cancer following treatment for breast cancer: a case-control study in Denmark

21 November 2022

14

1 reference

https://api.crossref.org/works/10.1080/1120009X.1991.11739104

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers

21 November 2022

15

1 reference

https://api.crossref.org/works/10.1080/1120009X.1991.11739104

Endometrial hyperplasia in an oophorectomized woman receiving tamoxifen therapy. Case report

21 November 2022

16

1 reference

https://api.crossref.org/works/10.1080/1120009X.1991.11739104

Four case reports presenting new acquisitions on the association between breast and endometrial carcinoma

21 November 2022

17

1 reference

https://api.crossref.org/works/10.1080/1120009X.1991.11739104

Tamoxifen as risk factor for carcinoma of corpus uteri

21 November 2022

19

1 reference

https://api.crossref.org/works/10.1080/1120009X.1991.11739104

Tamoxifen-associated endometrial carcinoma in postmenopausal breast cancer patients

21 November 2022

21

1 reference

https://api.crossref.org/works/10.1080/1120009X.1991.11739104

Anti-oestrogens in the treatment of breast and gynaecological cancers

21 November 2022

22

1 reference

https://api.crossref.org/works/10.1080/1120009X.1991.11739104

Tamoxifen for breast cancer: associated endometrial cancer

21 November 2022

23

1 reference

https://api.crossref.org/works/10.1080/1120009X.1991.11739104

21 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1779263%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

1 reference